Opportunities to Improve Care of Hepatocellular Carcinoma in Vulnerable Patient Populations
Overview
Gynecology & Obstetrics
Affiliations
Background: Hepatocellular carcinoma (HCC) patients with Medicaid or no health insurance have inferior survival compared with privately insured patients. Safety-net hospitals that care for these patients are often criticized for their inferior outcomes. We hypothesized that HCC survival was related to appropriate surgical management.
Study Design: The American College of Surgeons National Cancer Database was queried for patients diagnosed with HCC (n = 111,481) from 1998 to 2010. Hospitals were stratified according to safety-net burden, defined as the percentage of patients with Medicaid or no insurance. The highest quartile, representing safety-net hospitals, was compared with lower-burden hospitals with regard to patient demographics, cancer presentation, surgical management, and survival.
Results: Patients at safety-net hospitals were less often white, had less income and education, but presented with similar stage HCC. Safety-net hospital patients were less likely to receive surgery (odds ratio 0.77; p < 0.01), and among curable patients (stages 1 and 2) who underwent surgical intervention, liver transplantation and resection were performed less often at safety-net hospitals than at other hospitals (50.7% vs 66.7%). Procedure-specific mortality rates were also higher at safety net hospitals (p < 0.01). However, multivariate analysis adjusting for cancer stage and type of surgery revealed similar survival for safety-net hospital patients who had surgery and survived for longer than 30 days (p = 0.73).
Conclusions: Vulnerable patients with HCC are commonly treated at safety-net hospitals, are less likely to receive curative surgery, and have worse short-term outcomes. However, safety-net patients who can endure liver surgery have a similar prognosis as patients at nonsafety-net hospitals. Providing equal access to surgery may improve survival for vulnerable populations of HCC patients.
Choi H, Kim S, Shum D, Huang C, Shui A, Fox R Radiol Imaging Cancer. 2024; 6(1):e230118.
PMID: 38214600 PMC: 10825700. DOI: 10.1148/rycan.230118.
Surgical Cancer Care in Safety-Net Hospitals: a Systematic Review.
Wong P, Victorino G, Sadjadi J, Knopf K, Maker A, Thornblade L J Gastrointest Surg. 2023; 27(12):2920-2930.
PMID: 37968551 DOI: 10.1007/s11605-023-05867-7.
Swords D, Newhook T, Tzeng C, Massarweh N, Chun Y, Lee S Ann Surg Oncol. 2023; 30(12):7309-7318.
PMID: 37679537 DOI: 10.1245/s10434-023-14132-9.
Current status of disparity in liver disease.
Sempokuya T, Warner J, Azawi M, Nogimura A, Wong L World J Hepatol. 2022; 14(11):1940-1952.
PMID: 36483604 PMC: 9724102. DOI: 10.4254/wjh.v14.i11.1940.
Muslim Z, Razi S, Poulikidis K, Latif M, Weber J, Connery C JTCVS Open. 2022; 11:272-285.
PMID: 36172419 PMC: 9510853. DOI: 10.1016/j.xjon.2022.05.020.